Nuvo Pharmaceuticals Inc MRVFF:OTCQX

RT Quote | Exchange | USD
Last | 02/25/21 EST
1.45UNCH (UNCH)
52 week range
0.30 - 1.93

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.45
  • 52 Week High1.93
  • 52 Week High Date01/29/21
  • 52 Week Low0.30
  • 52 Week Low Date04/09/20
  • Market Cap16.14M
  • Shares Out11.39M
  • 10 Day Average Volume6,108.22
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change120.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.46
  • P/E (TTM)-3.14
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Nuvo Pharmaceuticals Inc News

There is no recent news for this security.

Latest MRVFF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Nuvo Pharmaceuticals Inc, formerly Nuvo Research Inc, is a Canada-based healthcare company. The Company offers a range of commercial products, including Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine (HLT) patch. The Company's Pennsaid 2% is a non-steroidal anti-inflammatory drug (NSAID) containing 2% diclofenac sodium. Its Pennsaid 2% is indicated for treating the pain of osteoarthritis (OA) of the knee and also acute strains and sprains. The Company's Pennsaid is...
Robert Harris
Chairman
Jesse Ledger
President
Mary-Jane Burkett
Chief Financial Officer
Katina Loucaides
Vice President
Calogero Lunetta
Vice President
Address
6733 Mississauga Rd Suite 610
Mississauga, ON
L5N 6J5
Canada